FuturHealth is a personalized health and wellness platform that blends nutrition, lifestyle guidance, and access to GLP-1 medication to help people optimize their health at every stage of life. With a network of 350+ providers across 48 states, FuturHealth has transformed the lives of over 1.5 million patients and counting. In under a year, it has achieved an extraordinary 980% growth in active patients. They’ve partnered with a number of other notable brands, including Apple Fitness+ and Affirm. Pulse 2.0 interviewed FuturHealth co-founder and CEO Luke Mahoney and President and co-founder John Levan to gain a deeper understanding of the company.
Background Of The Founders
Luke Mahoney is the co-founder and CEO of FuturHealth with a successful track record as a DTC marketing expert, serial entrepreneur, and founder, driving triple-digit growth and strategic execution for multiple health tech companies. Luke is passionate about integrating nutrition and wellness, particularly through the use of GLP-1 medications. His commitment to holistic health solutions reflects his belief that sustainable wellness is achievable through personalized care and education.
John Levan is the President and co-founder of FuturHealth, where he is responsible for product development and conversion rate optimization to deliver comprehensive solutions that meet the evolving needs of the GLP-1 and weight management market. His extensive experience in brand development and business strategy has been instrumental in establishing FuturHealth as the fastest-growing GLP-1 company in the industry. John holds a Bachelor’s degree in Science Multimedia Arts from Duquesne University and resides in San Diego, CA.
Formation Of The Company
How did the idea for the company come together? Mahoney and Levan said:
“Growing up in New Zealand, Luke was raised in a holistic manner where you can eat whatever you want and not worry about the effect it could have on your well-being. When he moved to the U.S., he noticed right away how restrictive people are when it comes to eating. Although lifestyle differences play a role, the way food is prepared and consumed in the U.S. is quite distinct from other countries. When it comes to weight gain, it’s an incredibly personal and individualized journey, often requiring a tailored approach. Some people might run every day without seeing progress toward their wellness goals, while for others, nutrition support could make all the difference.”
“We started FuturHealth to provide consumers with a holistic, personalized approach to weight loss and give people access to all of the options that could help them reach their goals – whether that’s medication, nutrition changes, and/or lifestyle coaching.”
“We are committed to addressing a key gap in the wellness industry: the lack of tools for GLP-1 users to transition off medications and adopt lasting lifestyle changes. The problem is that the majority of people who use GLP-1s for weight loss end up gaining back two-thirds of the weight after stopping the medication. To solve this, Luke and John have created sustainable and comprehensive weight-loss solutions complete with custom meal plans that integrate seamlessly with GLP-1 medications so users continue experiencing results after stopping the medication.”
Favorite Memory
What has been your favorite memory working for the company so far? Mahoney and Levan reflected:
“A recent trip to New York in February 2025 stands out as a major highlight. We had the incredible opportunity to meet with employees and partners who are now part of our company, as well as connect with key players in the health tech space. It was energizing to see the enthusiasm for what we’ve built and to engage with enterprises that truly recognized our impact. Moments like these put everything into perspective, serving as a powerful reminder of why we keep pushing forward every day.”
Core Products
What are the company’s core products and features? Mahoney and Levan explained:
“With a team of top doctors, dietitians, and health experts, FuturHealth seamlessly combines scientifically proven medications with expertly designed, clinically curated meals—making weight loss quick, easy, effective, and affordable.”
“By pairing personalized medication and nutrition, FuturHealth accelerates results, helping users achieve their goals and transition off GLP-1s efficiently. Our platform provides access to both branded and compounded medications, along with step-by-step nutrition guidance—all housed in a personalized portal. With features like effortless photo-based calorie tracking and clear instructions on medication administration, FuturHealth serves as a constant, supportive guide.”
“Additionally, our flexible supply chain navigates MSOs and pharmacies to ensure seamless service and cost savings. If one network experiences delays, FuturHealth instantly reroutes, keeping patients on track without disruption. Plus, our proprietary smart quiz simplifies eligibility, making the process smooth and accessible for all.”
Challenges Faced
What challenges have Mahoney, Levan, and the team faced in building the company? Mahoney and Levan acknowledged:
“Yes, one of the biggest challenges we’ve faced is scaling at a rapid pace, which requires not just hiring more people but also investing in the right people. While it may seem straightforward, building a strong team and ensuring a cultural fit is incredibly complex and demands experienced leadership.”
Evolution Of The Company’s Technology
How has the company’s technology evolved since its launch? Mahoney and Levan noted:
“At FuturHealth, we’re continuously innovating to better serve our customers—whether by expanding our network of expert physicians or enhancing our AI meal companion technology with new, guided options. Now, with the support of two distinct MSO partners, we’ve made our platform even more scalable, giving users more options, faster approvals, and seamless access to top weight-loss specialists.”
“Our technology is powered by a dynamic business intelligence layer that anticipates user needs before they arise, ensuring no one is left behind in their health journey. From AI-driven meal scanning that analyzes food choices and offers real-time GLP-1-friendly recommendations to a highly intuitive platform that streamlines care, we’re making it easier than ever for users to achieve the best possible health outcomes.”
“We also uphold the highest standards of quality and safety when it comes to medications. All prescriptions are sourced exclusively from licensed, U.S.-based pharmacies and FDA-approved manufacturers. As a LegitScript-certified company, we work only with U.S.-licensed clinicians to provide reliable, medically supported care every step of the way.”
Significant Milestones
What have been some of the company’s most significant milestones? Mahoney and Levan cited:
“From the start, our team has been on a mission to pioneer holistic and personalized solutions that merge cutting-edge science with practical nutrition. At FuturHealth, we believe that successful weight management isn’t just about medication—it’s about creating a comprehensive, sustainable approach to health.”
“In February, we launched our first efficacy data study, reinforcing what we’ve known all along: When you combine the right treatment with the right support system, you unlock far greater results. The study provides strong evidence that FuturHealth’s approach amplifies the benefits of GLP-1 medications, including:
1.) 5% more body weight change for compounded Semaglutide patients on the FH Program for 6 months versus medication alone.
2.) 3% more body weight change for compounded Tirzepatide patients on the FH Program for 6 months versus medication alone.
3.) FH Tirzepatide users – Lose on average 13% of their starting body weight over 6 months.
4.) Lose an average of 30 lbs. over 6 months.
5.) Reduce BMI by an average of 4.76 kg/m² over 6 months – FH Semaglutide users: Lose on average 12% of their starting body weight over 6 months.
6.) Lose an average of 25 lbs. over 6 months.
7.) Reduce BMI by an average of 4.1 kg/m² over 6 months.
We’ve also partnered with Valisure, a technology company providing independent quality assurance through chemical analysis, to continue strengthening our promise to deliver not only the most effective solutions but also the safest, highest-quality medications available.”
Customer Success Stories
Can you share any specific customer success stories? Mahoney and Levan highlighted:
“1.) Virginia, 73 years old– In just seven months with FuturHealth, Virginia went from 198 to 160 pounds, gaining control over her portions and rediscovering her love for exercise and horseback riding. With improved balance and movement, she’s thrilled with her progress and hopeful to lose 30 more pounds.
2.) Kelly, 62 years old – After struggling with weight her entire life and regaining half of what she lost from weight loss surgery, Kelly turned to FuturHealth and has already shed 49 pounds. With drastically reduced joint pain, a curbed appetite, and no side effects, she’s confident this affordable solution will help her reach her goal of losing another 40–50 pounds.”
Funding
When asking Mahoney and Levan about the company’s funding details, they revealed:
“We took a small seed round from strategic investors we trust, with the mindset of doing more with less. At this time, we don’t have plans to raise additional capital and are focused on growing as fast as possible with the resources we have. That approach has already led to 200K customers in our first year and tens of millions of people engaging with our health quiz.”
Total Addressable Market
What total addressable market (TAM) size is the company pursuing? Mahoney and Levan assessed:
“The total addressable market is expanding rapidly as these drugs are being used for a growing range of applications, from weight management to sleep and even microdosing. Goldman Sachs projects that the GLP-1 market will reach $130 billion in revenue by 2030, and we believe the potential is even greater as innovation and adoption continue to accelerate.”
Differentiation From The Competition
What differentiates the company from its competition? Mahoney and Levan affirmed:
“FutureHealth is the only platform to pair nutrition with medication through dedicated meals and meal plans prescribed by a dietician. Now, coupled with our recent efficacy data study, it further solidifies the importance of our business model and helping patients not only lose weight but keep the weight off sustainably.”
“These meals play a crucial role in FuturHealth’s 360-degree holistic approach to care through dedicated support, food, and medication to help users get on and stay on the path to sustainable wellness – while on and once they get off GLP-1s.”
Future Company Goals
What are some of the company’s future goals? Mahoney and Levan concluded:
“Our goal is to build the most powerful medical weight loss digital program by combining medication, nutrition coaching, and a suite of unique tools that empower individuals to achieve their best selves.
Looking ahead, we aim to support users not only in their weight loss journey but also in long-term health maintenance—whether that means transitioning off medication, adopting a sustainable lifestyle program, or ultimately needing no program at all.”
